PT1100824E - Compostos com propriedades de libertação da hormona de crescimento - Google Patents

Compostos com propriedades de libertação da hormona de crescimento Download PDF

Info

Publication number
PT1100824E
PT1100824E PT99929114T PT99929114T PT1100824E PT 1100824 E PT1100824 E PT 1100824E PT 99929114 T PT99929114 T PT 99929114T PT 99929114 T PT99929114 T PT 99929114T PT 1100824 E PT1100824 E PT 1100824E
Authority
PT
Portugal
Prior art keywords
growth hormone
compounds
hormone releasing
releasing properties
properties
Prior art date
Application number
PT99929114T
Other languages
English (en)
Inventor
Michael Ankersen
Bernd Peschke
Thomas Kruse Hansen
Stefan Lutz Richter
Original Assignee
Helsinn Therapeutics Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsinn Therapeutics Us Inc filed Critical Helsinn Therapeutics Us Inc
Publication of PT1100824E publication Critical patent/PT1100824E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
PT99929114T 1998-06-30 1999-06-29 Compostos com propriedades de libertação da hormona de crescimento PT1100824E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199800857 1998-06-30
DKPA199801440 1998-11-09

Publications (1)

Publication Number Publication Date
PT1100824E true PT1100824E (pt) 2011-06-16

Family

ID=26064788

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99929114T PT1100824E (pt) 1998-06-30 1999-06-29 Compostos com propriedades de libertação da hormona de crescimento

Country Status (20)

Country Link
EP (1) EP1100824B1 (pt)
JP (1) JP4511040B2 (pt)
KR (1) KR100907638B1 (pt)
CN (1) CN1304424C (pt)
AT (1) ATE500269T1 (pt)
AU (1) AU771644B2 (pt)
BR (1) BRPI9911756B1 (pt)
CA (1) CA2334315C (pt)
CY (1) CY1111509T1 (pt)
CZ (1) CZ299648B6 (pt)
DE (1) DE69943239D1 (pt)
DK (1) DK1100824T3 (pt)
HU (1) HUP0102460A3 (pt)
IL (1) IL140044A0 (pt)
NO (1) NO331351B1 (pt)
PL (1) PL199853B1 (pt)
PT (1) PT1100824E (pt)
RU (1) RU2298547C2 (pt)
TW (1) TW593337B (pt)
WO (1) WO2000001726A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1425029A4 (en) * 2001-08-10 2006-06-07 Palatin Technologies Inc PEPTIDOMIMETICS OF BIOLOGICALLY ACTIVE METALLOPEPTIDES
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
US20050261201A1 (en) * 2004-03-30 2005-11-24 Rejuvenon Corporation Method of reducing C-reactive protein using growth hormone secretagogues
KR20130048793A (ko) * 2004-08-12 2013-05-10 헬신 세라퓨틱스 (유.에스.) 인크. 성장 호르몬 분비촉진제를 이용하여 위장관계의 운동성을 촉진하는 방법
EP1883627B1 (en) * 2005-05-18 2018-04-18 Pharmascience Inc. Bir domain binding compounds
EP1951698A4 (en) 2005-10-25 2010-04-28 Aegera Therapeutics Inc BINDING COMPOUNDS TO THE IAP BIR DOMAIN
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
AU2008241532A1 (en) 2007-02-09 2008-10-30 Tranzyme Pharma, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same
CN107382827B (zh) * 2017-04-14 2021-01-01 江苏普莱医药生物技术有限公司 氨基酸衍生物或其药学上可接受的盐及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ258412A (en) * 1992-12-11 1997-01-29 Merck & Co Inc Spiro-fused piperidine derivatives and pharmaceutical compositions
WO1997000894A1 (en) * 1995-06-22 1997-01-09 Novo Nordisk A/S Compounds with growth hormone releasing properties
AU715856B2 (en) * 1995-12-22 2000-02-10 Novo Nordisk A/S Compounds with growth hormone releasing properties
DE69734215T2 (de) * 1996-07-22 2006-06-29 Novo Nordisk A/S Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften
AU7906998A (en) * 1997-06-20 1999-01-04 Novo Nordisk A/S Compounds with growth hormone releasing properties

Also Published As

Publication number Publication date
HUP0102460A2 (hu) 2001-11-28
KR20010053310A (ko) 2001-06-25
CA2334315A1 (en) 2000-01-13
DK1100824T3 (da) 2011-06-20
CA2334315C (en) 2011-07-26
JP4511040B2 (ja) 2010-07-28
EP1100824B1 (en) 2011-03-02
TW593337B (en) 2004-06-21
BRPI9911756B1 (pt) 2016-06-14
PL199853B1 (pl) 2008-11-28
IL140044A0 (en) 2002-02-10
RU2298547C2 (ru) 2007-05-10
HUP0102460A3 (en) 2001-12-28
JP2002519436A (ja) 2002-07-02
CN1307588A (zh) 2001-08-08
AU4603899A (en) 2000-01-24
KR100907638B1 (ko) 2009-07-14
CZ299648B6 (cs) 2008-10-01
AU771644B2 (en) 2004-04-01
NO20006699D0 (no) 2000-12-29
CY1111509T1 (el) 2015-08-05
NO20006699L (no) 2001-02-28
BR9911756A (pt) 2001-04-03
PL345204A1 (en) 2001-12-03
CN1304424C (zh) 2007-03-14
EP1100824A1 (en) 2001-05-23
ATE500269T1 (de) 2011-03-15
CZ20004565A3 (en) 2001-06-13
WO2000001726A1 (en) 2000-01-13
NO331351B1 (no) 2011-12-05
DE69943239D1 (de) 2011-04-14

Similar Documents

Publication Publication Date Title
IL139090A0 (en) Compounds with growth hormone releasing properties
MY117032A (en) A novel compound form.
DE69905170D1 (en) Thiazolopyrimidinderivate
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
YU13301A (sh) Muskarinski agonisti i antagonisti
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
IL140044A0 (en) Compounds with growth hormone releasing properties
BG101401A (en) Cisaspide extended release oral compositions
MXPA00007394A (es) Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas.
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
PL352104A1 (en) Oral composition containing perlite
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL142579A0 (en) Compounds with growth hormone releasing properties
IL137007A0 (en) Compounds with growth hormone releasing properties
HUP0200637A2 (en) Compounds, compositions, and their use for stimulating neuronal growth and elongation
ZA200201384B (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacyloalkene-2-one.
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь